.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Merck
Chubb
Novartis
Chinese Patent Office
Moodys
US Department of Justice
Queensland Health
Boehringer Ingelheim
Harvard Business School

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050441

« Back to Dashboard
NDA 050441 describes CLEOCIN PHOSPHATE, which is a drug marketed by Pharmacia And Upjohn and is included in four NDAs. It is available from three suppliers. Additional details are available on the CLEOCIN PHOSPHATE profile page.

The generic ingredient in CLEOCIN PHOSPHATE is clindamycin phosphate. There are fifty-three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

Summary for 050441

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 050441

Ingredient-typeLincosamides
Physiological EffectDecreased Sebaceous Gland Activity

Suppliers and Packaging for NDA: 050441

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLEOCIN PHOSPHATE
clindamycin phosphate
INJECTABLE;INJECTION 050441 NDA Pharmacia and Upjohn Company LLC 0009-0302 0009-0302-25 25 VIAL in 1 CARTON (0009-0302-25) > 2 mL in 1 VIAL (0009-0302-02)
CLEOCIN PHOSPHATE
clindamycin phosphate
INJECTABLE;INJECTION 050441 NDA Pharmacia and Upjohn Company LLC 0009-0602 0009-0602-25 25 VIAL in 1 CARTON (0009-0602-25) > 4 mL in 1 VIAL (0009-0602-04)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 150MG BASE/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
Harvard Business School
Cerilliant
Merck
Chubb
Queensland Health
Federal Trade Commission
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot